[Introduction] To determine how cell-cell contact with synovial fibroblasts (SF) influence on the proliferation and cytokine production of CD4 + T cells.
Introduction
Rheumatoid arthritis (RA) is a chronic inflammatory disorder that primarily affects the joints leading to their progressive destruction. The pathogenesis of RA is complex and includes many cell types, such as T cells, B cells, macrophages, and synovial fibroblasts (SF) (1).
SF are the major effector cells in RA synovitis (2) . They secrete large amount of inflammatory cytokines and proteolytic enzymes that lead to the formation of pannus and joint destruction. One crucial characteristic of RA-SF is the expression and upregulation of adhesion molecules that mediate the attachment of these cells to the cartilage, such as intracellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) (1). These adhesion molecules not only mediate the adhesion to the cartilage, but also deliver a signal for other lymphocytes such as CD4 + T cells (3, 4) . CD4 + T cells also play a critical role in the pathogenesis of RA. Classically, it has been hypothesized that IFN- producing Th1 cells play a major role in RA (5) . Recently, a new helper T cell subset secreting IL-17, Th17 cells, have been identified as the main effector cells in various autoimmune diseases in animal models (6, 7) , although the role of Th17 cells in human RA is still controversial (8) (9) (10) . It is reported that human naïve CD4 + T cells contain a Th17 progenitor cells that is characterized by the expression of CD161 (11) . CD161 + cells secrete not only IL-17 but also IFN- and are accumulated in the inflamed tissue of autoimmune diseases (11) (12) (13) .
In rheumatoid synovium, CD4 + T cells reside in close proximity to hyperplastic SF (14, 15) . SF in RA synovium upregulate ICAM-1 and VCAM-1, while CD4 + T cells in RA synovium upregulates their ligands, such as lymphocyte function associated antigen-1 (LFA-1) and very late antigen-4 (VLA-4), suggesting the possible interaction via adhesion molecules (15) . Previous works have revealed the bidirectional interaction between CD4 + T cells and SF, including cell surface expressed molecules and soluble factors (16) . For example, effector CD4 + T cells stimulate SF to produce inflammatory cytokines and proteolytic enzymes via several mechanisms (14, 15, 17, 18) . Conversely, SF influence on CD4 + T cell cytokine production via several mechanisms (17, (19) (20) (21) .
Interestingly, it is reported that SF have a unique character to induce the preferential production of IL-17 from CD4 + T cells, although the molecular mechanism have not been fully determined (17, (19) (20) (21) .
In this study, we tried to determine how cell-contact with SF influence on the proliferation and cytokine production of CD4 + T cells. To see the direct effect of SF for CD4 + T cells, we cultured naïve CD4 + T cells from healthy volunteers with SF from RA patients and assessed the proliferation and cytokine production after polyclonal anti-CD3 and/or anti-CD28 stimulation. We focused on how adhesion molecules which are highly upregulated on RA-SF act on the proliferation and cytokine production from CD4 + T cells.
Methods

Ethics
The study was designed in accordance with the declaration of Helsinki and was approved by the ethics committee of Kyoto University Graduate School and Faculty of Medicine. Written informed consent was obtained from all the participants.
Isolation of CD4 + T cells
Blood samples were obtained from healthy volunteers and RA patients. Peripheral blood mononuclear cell (PBMC) was isolated by Ficol (GE Healthcare Life Bioscience, Uppsala, Sweden) gradient centrifugation. Purification of CD4 + T cells and CD62L + naïve CD4 + T cells and separation of CD161 + CD62L + and CD161 -CD62L + CD4 + T cells were done by MACS (Milteny Biotech, Bergsh Gladbach, Germany) as manufacturer's instructions. The purity of naïve CD4 + T cells was 95~97 %.
Preparation of fibroblasts SF was obtained from surgical specimens in the total knee replacement surgery for RA or osteoarthrisis (OA) patients at Kyoto University Hospital. The RA patients fulfilled the American college of Rheumatology criteria for RA (22) . The OA patients were diagnosed according to the typical clinical signs and symptoms of American college of Rheumatology criteria for OA (23) . Briefly, tissue was minced and treated with 100 g/ml Liberase (Roche, Basel, Switzerland) and RPMI (Gibco, Carlsbad, USA) and rocked at 37 ℃ for 1h. The cell suspension was poured on 6 well treated plate (Greiner, Frickenhausen, Germany). SF was maintained in DMEM (Gibco) supplemented with 20% fetal bovine serum (Sigma Aldrich). SF on 4 to 10 passages were used as SF as previously described (2) . Dermal fibroblast (DF) obtained from healthy volunteer was kindly provided by Dr. Akihiko Kito (Department of Dermatology, Graduate School of Medicine, Kyoto University). Similar to SF, skin sample was minced and treated by Liberase and RPMI and rocked at 37 ℃ for 1h. The cell suspension was poured on 6 well treated plate. DF was maintained in DMEM supplemented with 20% fetal bovine serum (24) . and GM-CSF were 15 and 3 pg/mL, respectively. IFN-, IL-2, and TNF-levels were assessed by cytokine beads array as manufacturer's instructions (BD biosciences).
Samples were analyzed on FACSCalibur equipment (BD biosciences), and data were analyzed with FCAP array. The minimum detectable level of IFN-, IL-2, and TNF-were 3.7, 2.6 and 3.8 pg/mL, respectively.
Flow cytometry
The following antibodies were purchased from BD biosciences: IL-17-Alexa647 Data were presented as the mean ± SEM and statistical difference was analyzed by student t-test. P values less than 0.05 were considered significant.
Results
Cell-contact with synovial fibroblasts enhances CD4 + T cell proliferation and cytokine production.
To determine how SF influence on the proliferation and cytokine production of CD4 + T cells, we first cultured CD4 + T cells from RA patients with or without SF obtained from the same donor and stimulated them by anti-CD3 and CD28 antibodies ( Figure 1a Figure 3c ). Similar to IFN-, production of IL-2, GM-CSF, or TNF was also enhanced by plate-coated ICAM-1 or VCAM-1 (Supplementary Figure 3) . Interestingly, IL-17 production was markedly enhanced by plate-coated VCAM-1, but was scarcely induced by ICAM-1 (Figure 3c ), suggesting that VCAM-1 interaction is efficient for promoting IL-17 production from naïve CD4 + T cells. Figure 2) . Methotrexate, the most commonly used conventional synthetic DMARDs, or COX2 inhibitor might also have potential to down-regulate ICAM-1 and VCAM-1 expression on SF as shown for other cell types (25, 26) . Anti-ICAM-1 monoclonal antibody has been used for RA and were effective for suppressing RA and IFN- production (27) . Anti-VLA-4 antibody has been used for multiple sclerosis patients in which the role of Th17 cells are implicated for its pathogenesis (28) . The combined blockade of ICAM-1 and VCAM-1 might be more beneficial for inhibiting RA synovitis.
ICAM-1 and VCAM-1 had a differential effect for the rapid IFN-/IL-17 production from naïve CD4 + T cells. Although ICAM-1 is known to have the capacity to promote IL-17 production from CD4 + T cells (29) , our work suggested that VCAM-1/VLA-4 interaction may be more efficient for promoting the rapid production of IL-17 from human CD4 + T cells. Specific expression of VCAM-1 on SF but not dermal fibroblast might in part explain why SF have a unique character to promote preferential IL-17 production from CD4 + T cells as previously reported (17, (19) (20) (21) . CD161 + naïve CD4 + T cells which expressed high level of VLA-4 and, to a lesser extent, LFA-1 were the main source of ICAM-1-and VCAM-1-mediated IFN-/IL-17 production. We speculate that IL-17 production from CD161 + CD62 + naïve CD4 + T cells is not the contamination of effector/memory CD4 + T cells, because CD161 + T cells are present even in truly naïve T cells in the cord blood (11) . However, in vitro induction of human Th17 cells from naive CD4 + T cells is known to be challenging (30) . Therefore, it should be determined in the future whether truly naïve cord blood CD161 + cells have the capacity to respond ICAM-1/VCAM-1 and secrete IFN-/IL-17. The rapid expansion of CD161 + cells upon interaction with ICAM-1 and VCAM-1 may be one reason why CD161 + cells are accumulated in the inflamed tissues of RA and other autoimmune diseases (11) (12) (13) .
Because this is an in vitro experiment culturing naïve CD4 + T cells with SF and stimulated with polyclonal anti-CD3/28 antibody, the in vivo relevance of this study remains to be determined. This is the major limitation of our study. 
